Hasil Pencarian - Ana Maria Arance

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    194 Characterization of the pharmacodynamic activity of CLN-619, an anti-MICA/B monoclonal antibody, in patients from an ongoing Phase 1 trial

    194 Characterization of the pharmacodynamic activity of CLN-619, an anti-MICA/B monoclonal antibody, in patients from an ongoing Phase 1 trial oleh Victor Moreno, Ignacio Melero, Michael Millward, Tracy Liu, Rafał Stec, Erika Hamilton, Ana Maria Arance, Jennifer S Michaelson, Laura Liu, Alexander I Spira, Judy S Wang, Irina M Shapiro, Kerry A Whalen, Jeffrey A Jones

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    770 ADU-1604, a novel CTLA-4 blocking antibody modulates pharmacodynamic markers in PD1 relapse/refractory melanoma patients

    770 ADU-1604, a novel CTLA-4 blocking antibody modulates pharmacodynamic markers in PD1 relapse/refractory melanoma patients oleh Caroline Robert, Ivan Marquez-Rodas, Michele Maio, Vanna Chiarion-Sileni, Piotr Rutkowski, Hans Van Eenennaam, Julien Villaudy, Jessica Kundapur, Ana Maria Arance, Alexander Eggermont, Guillemo De Velasco Oria de Rueda, Laura Lassouw-Polman

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    389 Phase II of CD40 agonistic antibody sotigalimab (APX005M) in combination with nivolumab in subjects with metastatic melanoma with confirmed disease progression on anti-PD-1 therapy

    389 Phase II of CD40 agonistic antibody sotigalimab (APX005M) in combination with nivolumab in subjects with metastatic melanoma with confirmed disease progression on anti-PD-1 the... oleh Enriqueta Felip, Mario Sznol, Harriet Kluger, Erin Filbert, Valentina Boni, Montaser Shaheen, Nicholas Iannotti, Delvys Rodriguez-Abreu, Maria Gonzalez-Cao, Alfonso Berrocal, Ralph Hauke, Lynn Schuchter, Gerald Linette, Sarah Weiss, Miguel-Ángel Berciano-Guerrero, Ana Maria Arance, Apar Kishor Ganti

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study

    Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study oleh Stéphane Dalle, Laurent Mortier, Pippa Corrie, Michal Lotem, Ruth Board, Ana María Arance, Frank Meiss, Patrick Terheyden, Ralf Gutzmer, Brian Buysse, Kelly Oh, Jane Brokaw, T. Kim Le, Susan D. Mathias, Julie Scotto, Jennifer Lord-Bessen, Andriy Moshyk, Srividya Kotapati, Mark R. Middleton

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: